-
Mashup Score: 1US FDA issues alert over potential need for early device replacement of Boston’s Accolade pacemakers - 27 day(s) ago
The US Food and Drug Administration (FDA) has alerted patients, caregivers and healthcare providers about the potential need for early device replacement of Boston Scientific’s Accolade pacemakers—including the Accolade, Proponent, Essentio and Altrua 2 Standard Life (SL) and Extended Life (EL) pacemakers, and the Visionist and Valitude cardiac resynchronisation therapy pacemakers. In a safety communication […]
Source: cardiacrhythmnews.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Manipal Hospitals successfully performs eastern India's first AI-powered wireless pacemaker insertion - 29 day(s) ago
Manipal Hospitals—one of the largest healthcare networks in India—has announced the successful insertion of an artificial intelligence (AI)-driven wireless injectable pacemaker. The Aveir leadless pacemaker (Abbott), recently introduced in India, was implanted in a 65-year-old woman at Manipal Hospital (Kolkata, India), making it the first centre in eastern India to perform this procedure. The device, […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Pilot study shows cryoablation safe and effective for patent foramen ovale closure in AF patients - 30 day(s) ago
New research suggests that cryoablation is a safe and effective approach to closing congenital patent foramen ovale (PFO) in patients with atrial fibrillation (AF) undergoing pulmonary vein isolation (PVI) as part of a single procedure. A study published in the journal Heart Rhythm details this alternative method to the conventional treatment of implementing a percutaneous […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Texas Cardiac Arrhythmia Institute becomes first in USA to use FDA-approved mapping and dual-energy ablation catheter - 1 month(s) ago
Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St David’s Medical Center (Austin, USA) recently became the first in the USA to use an all-in-one, high-density mapping and dual-energy ablation catheter (Affera [Medtronic]) for the treatment of persistent atrial fibrillation (AF) and atrial flutter following its receipt of approval by the US Food and […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Accurate prediction of sudden cardiac death following heart attack “currently not feasible” - 1 month(s) ago
New research published in the European Heart Journal has shown that, among patients who have had a heart attack, it is “extremely difficult” to accurately predict those who will go on to suffer a sudden cardiac death—even in those with a left ventricular ejection fraction (LVEF) of 35% or lower, which is commonly used as a justification […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0COVID-19 vaccination “generally not associated” with increased thromboembolic event risk in AF and atrial flutter patients - 1 month(s) ago
In patients with atrial fibrillation (AF) or atrial flutter, COVID-19 vaccination appears to be “generally not associated with an increased risk of thromboembolic events”, as per the findings of a recent study led by researchers in South Korea. In addition to their study’s main conclusion, the researchers note—writing in the European Heart Journal—that “careful individual […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Two innovative ECG monitors obtain new US FDA clearances - 1 month(s) ago
Two innovative electrocardiogram (ECG) products have gained new US Food and Drug Administration (FDA) clearances for monitoring cardiac arrhythmias—Fourth Frontier’s Frontier X Plus (FX+) and SmartCardia’s seven-lead (7L) patch. Both clearances were announced by the respective companies on 13 November. “We have seen cardiac arrhythmias develop in individuals of all ages, and the incidence is […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Defibrillation devices could remain effective while using 1,000 times less electricity - 1 month(s) ago
In a paper published recently in the journal Chaos, researchers from Sergio Arboleda University (Bogotá, Colombia) and the Georgia Institute of Technology (Atlanta, USA) used an electrophysiological computer model of the heart’s electrical circuits to examine the effect of the applied voltage field in multiple fibrillation-defibrillation scenarios—and discovered that far less energy is needed compared to […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0University of Kansas Health System enhances robotic heart care programme with Genesis technology - 1 month(s) ago
Stereotaxis has announced that physicians at the University of Kansas Health System (Kansas City, USA)—a system renowned for diagnosing and treating complex heart conditions—have successfully treated the first patients using the company’s advanced Genesis robotic magnetic navigation (RMN) system. According to a Stereotaxis press release, the Genesis system is the latest advancement in RMN technology, […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Collaboration attempts to establish research capacity for ambulatory rhythm monitoring in sub-Saharan Africa - 2 month(s) ago
A recent study published in JACC: Clinical Electrophysiology has placed emphasis on the importance of building research capacity for ambulatory rhythm monitoring in sub-Saharan Africa, where such services are currently scarce. Conducted in collaboration with the University of California San Francisco (UCSF), Weill Cornell Medicine (New York, USA) and Cardiomatics, the study can be seen […]
Source: cardiacrhythmnews.comCategories: General Medicine News, CardiologistsTweet
The @US_FDA has alerted patients, caregivers and healthcare providers about the potential need for early device replacement of @bostonsci's Accolade pacemakers https://t.co/LeW9rgXVU1